International Journal of Medical Research & Health Sciences (IJMRHS)
ISSN: 2319-5886 Indexed in: ESCI (Thomson Reuters)
BR Ahir
Department of Pharmacology, B.J. Medical College, Ahmedabad, IndiaPublications
-
Research
Cost Comparison of Different Brands of Anti-Diabetic Drugs With Drug Prices Control Order Price List
Author(s): MN Solanki, BR Ahir* and CK Desai
Introduction: India, the “diabetes capital” of the world, 74 million diabetics with a prevalence of ~8.7% among the adult population. People require lifelong treatment for diabetes. Six of the top 10 drugs sold in India are anti-diabetes brands. For most multinational drug makers the diabetes market has been highly lucrative. Objective: This study was undertaken to compare the price of anti-diabetic branded drugs with the Drug Price Control Order (DPCO) price list. Methods: This is a cross-sectional, observational study. The price of different branded anti-diabetic drugs (included in NLEM) was obtained from drug compendia and different pharmacy stores situated in five zones of Ahmedabad. A comparison was done between the price of branded drugs in compendia, Pharmacy store, and DPCO ceiling price to find o.. Read More»
DOI: 0
Select your language of interest to view the total content in your interested language